Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine: Audio-slides

Published: 11 February 2020| Version 1 | DOI: 10.17632/cj98sw6zr5.1
Contributors:
pierre van damme,
Geert Leroux-Roels,
Corinne Vandermeulen,
Iris De Ryck,
Annaelisa Tasciotti,
Marie Dozot,
Luca Moraschini,
Marco Testa,
Ashwani Kumar Arora

Description

These audio-slides support the published article Pierre Van Damme, Geert Leroux-Roels, Corinne Vandermeulen, Iris De Ryck, Annaelisa Tasciotti, Marie Dozot, Luca Moraschini, Marco Testa, Ashwani Kumar Arora. Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine. Vaccine. 2019;37(23):3113-3122. In this article, we provide evidence that an investigational non-typeable Haemophilus influenzae and Moraxella catarrhalis (NTHi-Mcat) protein vaccine has an acceptable safety and reactogenicity profile and good immunogenicity in older adults with smoking history.

Files